We concluded that silencing of miR-556-5p re-activated cisplatin-induced pyroptotic cell death via degrading NLRP3, resulting in the improvement of cisplatin-sensitivity in CR-NSCLC. This evidence concerns the gene NLRP3 and non-small cell lung carcinoma.